B. Cepacia Hits ICUs Again, Raises Manufacturing Controls Questions

Another outbreak of B. cepacia at hospital intensive care units in multiple states implicates manufacturing and supply chain controls on aqueous non-sterile drug products, particularly for those marketed over the counter under OTC monographs.